M. Roden

Epidemiology · 2010–2021

A researcher in the Science corpus: 15 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 141 citations into it
• Physiology — 75 citations into it
• Public Health, Environmental and Occupational Health — 21 citations into it

Whom M. Roden trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. K. Petersen

Papers from M. Roden's perspective

Ordered by how strongly the researchers M. Roden trusts endorse each paper. Same corpus, a different order for every researcher.

1. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
2. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
3. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. (New England Journal of Medicine)
4. Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
5. Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease (Cell Metabolism)
6. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
7. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts (Nature Protocols)
8. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
9. Defining the role of common variation in the genomic and biological architecture of adult human height
10. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations (Nature Genetics)

Their papers

• Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes (2012) — 1,982 citations
• Systematic identification of trans-eQTLs as putative drivers of known disease associations (2013) — 1,732 citations
• The transcriptional landscape of age in human peripheral blood (2015) — 654 citations
• Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis (2010) — 1,860 citations
• The genetic architecture of type 2 diabetes (2016) — 1,066 citations
• Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity (2016) — 815 citations
• Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
• The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments (2021) — 731 citations
• The integrative biology of type 2 diabetes (2019) — 974 citations
• An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans (2017) — 677 citations
• NAFLD and diabetes mellitus (2017) — 901 citations
• Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. (2015) — 919 citations
• Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility (2014) — 1,017 citations
• Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach (2013) — 949 citations
• Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions (2011) — 1,121 citations